TABLE 1.
Studies including more than one ethnicity | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Study | Author | Year | Country | Source | Mean age | Sex, % | FH criteria | Sample size, N | Total FH cases, N | Total prevalence, % | Ethnicities | Prevalence and ethnicity % | |
NHANES de Ferranti et al. (2016) | De Ferranti et al. | 2016 | United States | GP | 46.8 years | F: 51.4 | DLCN | 36,949 | 148 | 0.4 | Black, Latino, white, mixed/other | Black: 0.46 Latino: 0.37 white: 0.40 mix./oth.: 0.28 | |
M: 48.6 | |||||||||||||
ELSA-Brasil Harada et al. (2018) | Harada et al. | 2018 | Brasil | GP | HeFH: 55 years | F: 54 | DLCN | 14,460 | 55 | 0.38 | 16% black, 53% white, 29% mixed | Black: 0.67, white: 0.25, brown: 0.48 | |
M: 46 | |||||||||||||
The Cape Town Experience Firth and Marais (2008) | Firth et al. | 2008 | South Africa (Cape Town) | Patients from a lipid clinic | HeFH: 44 years | F: 53 | Clinical equal to modified DLCN | 4,494 | 1,029 | 23 | Black, white, Asian colored | Black: 4.90, white: 32.2, Asian: 19.8 mix./oth.: 17.2 | |
M: 47 | |||||||||||||
MyHEBAT FH Study, Malaysia Chua et al. (2021) | Chua et al. | 2021 | Malaysia | GP | 53.7 years | F: 62.6 | DLCN | 5,135 | 55 | 1.1 | Malay, Chinese, Indian, Others | Asian: 1.2%, Others: 0.4% | |
M: 38.4 | |||||||||||||
The Young MI Registry Singh et al. (2019) | Singh et al. | 2019 | United States | Young adults with MI | 45 years | F: 19.1 | DLCN | 1,996 | 180 | 9 | Black, hispanic/Latino, white, Asian, mixed/other | Black: 9.8, Latino: 14.0.98 white: 8.79, Asian: 4.3 mix./oth. : 8.1 | |
M: 80.9 | |||||||||||||
Studies including one ethnicity | |||||||||||||
Copenhagen City Heart Study, DK Tybjaerg-Hansen et al. (2005) | Tybjærg-Hansen et al. | 2005 | Denmark | GP | 53 years | F: 55 | DLCN | 9,255 | 15 | 0.17 | 100% white | White: 0.17 | |
M: 45 | |||||||||||||
Copenhagen General Population Study Benn et al. (2016) | Benn et al. | 2016 | Denmark | GP | NA | F: 55 | Genetic | 98,098 | 450 | 0.46 | 100% white | White: 0.46 | |
M: 45 | |||||||||||||
LIFE Child Health Cohort, GE Dathan-Stumpf et al. (2016) | Dathna-Stumpf et al. | 2016 | Germany | GP | 0–16 years | F:52.3 | Clinical HeFH | 2,571 | 6 | 0.23 | Caucasian | White: 0.23 | |
M: 47.7 | |||||||||||||
MyCode cohort, US Abul-Husn et al. (2016) | Abul-Husn et al. | 2016 | United States | GP | 61 years | F: 59.2, M: 40.8 | Genetic | 43,979 | 172 | 0.39 | 98.4% Caucasian | White: 0.39 | |
Allina Health ambulatory Facility, US Knickelbine et al. (2016) | Knickelbine et al. | 2016 | United States | GP | FH:53 No FH: 54.1 years | F: 55 | Clinical National Lipid Assoc. Guidelines | 391,166 | 841 | 0.21 | 90% white | White: 0.21 | |
M: 45 | |||||||||||||
Jiangsu Nutrition Study Wijesekera et al. (2014) | Shi et al. | 2014 | China | GP | 57 years | NA | DLCN | 9,324 | 26 | 0.28 | Asian | Asian: 0.28 | |
Kumamoto Health Care, Japan Ohta et al. (2002) | Ohta et al. | 2002 | Japan | GP | 18 months | NA | Clinical HeFH family study | 56,181 adj. size: 47,877 | 91 | 0.19 | Asian | Asian: 0.19 | |
Korean Meta. Syndrome Mortality Study Jung et al. (2018) | Jung et al. | 2018 | Korea | GP | 44.3 years | F: 42.6 | MEDPED | 502,966 | 540 | 0.11 | Asian | Asian: 0.19 | |
M: 57.4 |
GP, general population; F, female; M, male; HeFH, heterozygous familial hypercholesterolemia; DLCN, Dutch Lipid Clinic Network Criteria; MEDPED, Make Early Diagnosis Prevent Early Death; NA, not available.